Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trek: LT Patch for ETEC in Travelers
NCT00516659Phase 2Completed
- Sponsor
- Intercell AG
- Start
- May 2006
- Primary completion
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of travellers' diarrhoea vaccine patch in enterotoxigenic Escherichia coli infection, sponsored by Intercell AG. Started May 2006; status: completed.
02
Drugs
travellers' diarrhoea vaccine patch
03
Conditions
enterotoxigenic Escherichia coli infection
Beyond the preview
Go deeper on NCT00516659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00516659.